Immunodeficiency common variable and Copd

Summary:

Copd is found among people with Immunodeficiency common variable, especially for people who are female, 60+ old.

The study analyzes which people have Copd with Immunodeficiency common variable. It is created by eHealthMe based on reports of 365 people who have Immunodeficiency common variable from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Immunodeficiency common variable?

Immunodeficiency common variable is found to be associated with 87 drugs and 143 conditions by eHealthMe. Check the latest studies of Immunodeficiency common variable.

What is Copd?

Copd (chronic obstructive pulmonary disease) is found to be associated with 1,889 drugs and 2,196 conditions by eHealthMe. Check the latest studies of Copd.



On Apr, 12, 2026

365 people who have Immunodeficiency Common Variable and Copd are studied.

Would you have Copd when you have Immunodeficiency common variable?

Gender of people who have Immunodeficiency Common Variable and experienced Copd *:

  • female: 80.72 %
  • male: 19.28 %

Age of people who have Immunodeficiency Common Variable and experienced Copd *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.5700000000000001 %
  • 20-29: 0.0 %
  • 30-39: 0.5700000000000001 %
  • 40-49: 4.57 %
  • 50-59: 11.43 %
  • 60+: 82.86 %

Common co-existing conditions for these people *:

  1. Primary Immunodeficiency Syndrome: 49 people, 13.42%
  2. Immune System Disorder: 12 people, 3.29%
  3. Hypergammaglobulinaemia (elevated levels of gamma globulin): 11 people, 3.01%
  4. Asthma: 7 people, 1.92%
  5. Combined Immunodeficiency: 7 people, 1.92%
  6. Osteoporosis (bones weak and more likely to break): 7 people, 1.92%
  7. Neuropathy Peripheral (surface nerve damage): 7 people, 1.92%
  8. B-Lymphocyte Abnormalities (abnormal population of b lymphocytes in the blood, bone marrow, or tissues): 5 people, 1.37%
  9. Metabolic Disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues): 4 people, 1.10%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 1.10%

Common drugs taken by these people *:

  1. Epinephrine: 176 people, 48.22%
  2. Acetaminophen: 170 people, 46.58%
  3. Lidocaine: 102 people, 27.95%
  4. Sodium Chloride: 93 people, 25.48%
  5. Albuterol Sulfate: 91 people, 24.93%
  6. Aspirin: 91 people, 24.93%
  7. Prednisone: 84 people, 23.01%
  8. Vitamin D3: 83 people, 22.74%
  9. Spiriva: 75 people, 20.55%
  10. Proair Hfa: 69 people, 18.90%

Common symptoms for these people *:

  1. Pneumonia: 144 people, 39.45%
  2. Headache (pain in head): 71 people, 19.45%
  3. Fatigue (feeling of tiredness): 68 people, 18.63%
  4. Sinusitis (inflammation of sinus): 67 people, 18.36%
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 61 people, 16.71%
  6. Fall: 57 people, 15.62%
  7. Cough: 56 people, 15.34%
  8. Dyspnea (difficult or laboured breathing): 56 people, 15.34%
  9. Asthma: 50 people, 13.70%
  10. Urinary Tract Infection: 47 people, 12.88%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Copd?

- Check whether Copd is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Copd:

  • Copd (1,889 drugs)

All the conditions that are associated with Copd:

  • Copd (2,196 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Copd and Immunodeficiency common variable, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: